Inflammatory polyneuropathy, unspecified, is a group of neurological disorders caused by an immune system malfunction. The exact cause of the disorder is unknown, but it is believed to be triggered by an infection, autoimmune reaction, or exposure to a toxin.
The diagnosis of inflammatory polyneuropathy, unspecified, is made based on a physical examination and a review of a patient’s medical history. Tests such as nerve conduction studies and electromyography may be used to confirm the diagnosis.
Differential diagnosis for inflammatory polyneuropathy, unspecified, includes Guillain-Barre syndrome, chronic inflammatory demyelinating polyneuropathy, and multifocal motor neuropathy.
Treatment for inflammatory polyneuropathy, unspecified, may include medications such as immunosuppressants, steroids, and intravenous immunoglobulin. Other treatments may involve physical therapy, occupational therapy, and lifestyle modifications.
The prognosis for inflammatory polyneuropathy, unspecified, is generally good with proper treatment. Most patients are able to recover with minimal or no residual deficits. In some cases, however, the damage may be permanent.